As biotechnology becomes more central to new innovations in healthcare, material science, and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch companies focused on the commercialization of new technologies. Backed by the Boston-based venture capital firm, Pillar, Petri has a three-year $15 million commitment to back companies…